On May 1, 2020, Mr. Ming Li resigned as Chief Financial Officer of the Yew Bio-Pharm Group, Inc., in order to pursue other interests and businesses. On May 5, 2020, the Board of Directors appointed Mr. Zhiguo Wang as the new interim Chief Financial Officer of the Company. Mr. Wang is the CEO and President of the Company and has agreed to assume the office of CFO while the Board looks for another qualified person to become the permanent CFO.